Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle

2003 ◽  
Vol 275 (1-2) ◽  
pp. 99-112 ◽  
Author(s):  
Alberto L Horenstein ◽  
Federico Crivellin ◽  
Ada Funaro ◽  
Marcela Said ◽  
Fabio Malavasi
Keyword(s):  
Monoclonal Antibodies ◽  
Cancer Therapy ◽  
Downstream Processing ◽  
Proof Of Principle

scholarly journals Introduction and clearance of beta‐glucan in the downstream processing of monoclonal antibodies

2021 ◽  
Author(s):  
Simon Kluters ◽  
Karin Steinhauser ◽  
Roland Pfänder ◽  
Joey Studts
Keyword(s):  
Monoclonal Antibodies ◽  
Downstream Processing ◽  
Beta Glucan

Monoclonal Antibodies in Cancer Therapy

1996 ◽  
Vol 5 (3) ◽  
pp. 214-222 ◽  
Author(s):  
Elena Holz ◽  
Rudolf Gruber ◽  
Gert Riethmüller
Keyword(s):  
Monoclonal Antibodies ◽  
Cancer Therapy

APPLICATIONS OF MONOCLONAL ANTIBODIES IN CANCER THERAPY

1984 ◽  
Vol 40 (3) ◽  
pp. 240-246 ◽  
Author(s):  
R O DILLMAN ◽  
I ROYSTON
Keyword(s):  
Monoclonal Antibodies ◽  
Cancer Therapy

Monoclonal Antibodies for Cancer Therapy

2014 ◽  
pp. 2911-2919 ◽  
Author(s):  
Ingegerd Hellstrom ◽  
Karl Erik Hellstrom
Keyword(s):  
Monoclonal Antibodies ◽  
Cancer Therapy

Cancer chemotherapy and radiation therapy

2010 ◽  
pp. 396-404 ◽  
Author(s):  
Bruce A. Chabner ◽  
Jay Loeffler
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Monoclonal Antibodies ◽  
Cancer Therapy ◽  
Western World ◽  
Targeted Drugs ◽  
Germ Cell Tumours ◽  
Stage Disease ◽  
Late Stage Disease ◽  
Extended Survival

The last two decades have brought significant improvements in cancer therapy: patients with previously fatal diseases, including acute leukaemia, non-Hodgkin’s lymphoma, Hodgkin’s disease, and germ cell tumours, now have a high expectation of cure. For patients with the more common solid tumours, including lung, colon, and breast cancer, new chemotherapeutic and hormonal agents, molecularly targeted drugs, and monoclonal antibodies have improved treatment of both early and late stage disease and have extended survival. Nevertheless, cancer remains the second leading cause of death in the Western world, and nearly one third of patients diagnosed with cancer will die of their disease....

The vaccinal effect of monoclonal antibodies in cancer therapy

2014 ◽  
pp. 357-372
Author(s):  
Claire Deligne ◽  
Sophie Sibéril ◽  
Jean-Luc Teillaud
Keyword(s):  
Monoclonal Antibodies ◽  
Cancer Therapy
Sign in / Sign up

Export Citation Format

Share Document